---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-036194"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-08T23:12:02.801565+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Baxter Q3 2023 adjusted EPS $0.68 from continuing ops beats guidance; completes $4.25B BPS divestiture

## Summary
- Q3 revenue from continuing ops $3.71B (+3% reported, +2% CC), ahead of company guidance.
- GAAP EPS from continuing ops $0.09; adjusted EPS $0.68, exceeded prior guidance.
- Completed BioPharma Solutions divestiture for $4.25B; cash proceeds $3.96B; gain $2.89B; debt repayment use.
- Kidney Care spinoff on track to close by July 2024.
- FY 2023 adjusted EPS guidance $2.57-$2.60; Q4 2023 adjusted EPS guidance $0.85-$0.88.

## SEC filing metadata
- accession: 0001628280-23-036194
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828023036194/0001628280-23-036194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828023036194/bax-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-036194
- JSON: https://secwatch.observer/filing/0001628280-23-036194.json
- Plain text: https://secwatch.observer/filing/0001628280-23-036194.txt

## Key facts
- Earnings Releases
  BAXTER INTERNATIONAL INC reported third quarter 2023 results: revenue $3.71 billion, net income $2.51 billion, EPS $4.93 per diluted share.
  - Period: third quarter 2023
  - Revenue: $3.71 billion
  - Net income: $2.51 billion
  - EPS: $4.93 per diluted share
  - Result: reported results
  source text: BAXTER REPORTS THIRD-QUARTER 2023 RESULTS • Third-quarter revenue from continuing operations of $3.71 billion increased 3% on a reported basis and 2% on a constant currency basis, ahead of the company’s previously issued guidance 1 • Third-quarter U.S. GAAP earnings per share (EPS) from continuing operations of $0.09; adjusted EPS from continuing operations of $0.68 exceeded guidance • Third-quarter U.S. GAAP EPS in the aggregate (including discontinued operations) totaled $4.93; adjusted EPS in the aggregate (including discontinued operations) of $0.82 exceeded guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828023036194/0001628280-23-036194-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.